The role of Fbxw7 in genetic instability and cancer development ABSTRACT Genetic instability is one of the hallmarks of human cancers, particularly in the most common tumors of epithelial origin. The p53 gene is a tumor suppressor with an essential role in induction of growth arrest and apoptosis in response to DNA damage, and is involved in protection from genomic instability. The Fbxw7 gene is a direct transcriptional target of p53 that undergoes deletions and mutations in mouse lymphomas in a p53-dependent manner. Loss of the human FBXW7 gene also leads to genetic instability, and mutations have been detected in cancers from a wide spectrum of human tissues, such as bile duct, blood, bone, brain, breast, colon, endometrium, stomach, lung, ovary, pancreas, and prostate. Alteration of the Fbxw7 gene results in impaired degradation of multiple targets and their consequent accumulation, which may cooperatively contribute to tumor development. However it still remains largely unclear which target is most related to cancer development in Fbxw7-mutant cancer cells. The goal of the first aim is to investigate Fbxw7- mTOR pathway in cancer development. Our preliminary results have shown that mTOR is a new target of Fbxw7, and preliminary genetic analysis of gene copy number changes in human breast cancers gave rise to the intriguing possibility that deletions of FBXW7 and PTEN may be mutually exclusive. We will investigate whether mTOR is required for tumor development in Fbxw7-depelition cells and whether tumors harboring the alteration of Fbxw7 or Pten are sensitive to mTOR inhibitor, such as Rapamycin, treatment.
In aim 2, we will elucidate the role of Fbxw7-Aurora-A in genomic instability and tumor development. We will investigate the functional relationship between Fbxw7 and Aurora-A kinase in control of chromosome segregation and aneuploidy, both in vitro and in vivo.
In aim 3, we have demonstrated that a functional strain-dependent polymorphism in the N-terminus of Fbxw7 affects the activity of the protein, and influences susceptibility to lymphoma development. We will elucidate the mechanism of action of this genetic variant and determine its role in tumor susceptibility. Therefore we anticipate this project will address critically important questions related to the role of Fbxw7 in tumor development and tumor susceptibility, and possible clinical implications in the therapy of human cancer harboring alteration of FBXW7.

Public Health Relevance

FBXW7 is emerging as a major human tumor suppressor gene that has been mutated in cancers from a wide spectrum of human tissues, such as bile duct, blood, bone, brain, breast, colon, endometrium, stomach, lung, ovary, pancreas, and prostate. The understanding of the role of FBXW7 in tumor development and tumor susceptibility may provide novel preventive or therapeutic possibilities for many human cancers. 1

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA116481-04
Application #
7917484
Study Section
Cancer Genetics Study Section (CG)
Program Officer
Mietz, Judy
Project Start
2008-09-01
Project End
2013-07-31
Budget Start
2010-08-01
Budget End
2011-07-31
Support Year
4
Fiscal Year
2010
Total Cost
$355,982
Indirect Cost
Name
Lawrence Berkeley National Laboratory
Department
Biology
Type
Organized Research Units
DUNS #
078576738
City
Berkeley
State
CA
Country
United States
Zip Code
94720
Wang, Yuli; Zhang, Pengju; Wang, Yunshan et al. (2017) Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer. Cancer Res 77:1983-1996
Snijders, Antoine M; Lee, Sun-Young; Hang, Bo et al. (2017) FAM83 family oncogenes are broadly involved in human cancers: an integrative multi-omics approach. Mol Oncol 11:167-179
Yan, Hong; Bi, Lei; Wang, Yunshan et al. (2017) Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas. Sci Rep 7:333
Li, Chaoyang; Zhang, Pengju; Jiang, Anli et al. (2017) A short synthetic peptide fragment of human C2ORF40 has therapeutic potential in breast cancer. Oncotarget 8:41963-41974
Cañueto, J; Cardeñoso-Álvarez, E; García-Hernández, J L et al. (2016) MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma. Br J Dermatol :
Hu, Zhi; Mao, Jian-Hua; Curtis, Christina et al. (2016) Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancer. Breast Cancer Res 18:70
Blanco-Gómez, Adrián; Castillo-Lluva, Sonia; Del Mar Sáez-Freire, María et al. (2016) Missing heritability of complex diseases: Enlightenment by genetic variants from intermediate phenotypes. Bioessays 38:664-73
Walian, Peter J; Hang, Bo; Mao, Jian-Hua (2016) Prognostic significance of FAM83D gene expression across human cancer types. Oncotarget 7:3332-40
Zhang, Weiguo; Mao, Jian-Hua; Zhu, Wei et al. (2016) Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy. Nat Commun 7:12619
Snijders, Antoine M; Mao, Jian-Hua (2016) Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types. Adv Mod Oncol Res 2:215-223

Showing the most recent 10 out of 39 publications